By KETRA KALUNGACLINICAL trials on Ivermectin vaccine as an anti-parasitic drug will be closely monitored and regulated to ensure that it is not harmful to people, the Zambia Medicines Regulatory Authority (ZAMRA) has said.ZAMRA recently allowed clinical trials to study the efficacy of the veterinary anti-parasitic drug in the prevention of Covid-19, as was the case in neighbouring Zimbabwe and other countries.ZAMRA is set to work closely with the task force set up at the Ministry of Health to conduct vaccine trials to ensure that everyone involved in the study was protected.ZAMRA senior public relations officer, Christabel Illiamupu, said in an interview that it would work closely with the task force to safeguard lives once trials commence.Ms. Illiamupu said ZAMRA would ensure that trials were done in line with the guidelines which included ethical assessments of trial subjects.“As we mentioned in our earlier statement, these studies are impending, they are impending studies to explore the […]
Covid-19 vaccine trials under ZAMRA spotlight
